Alkermes ALKS Vivitrol — Actual Credits Received Related To Duplicate Billings

Similar metrics at other companies

JBTMUnbilled Revenue

$142M-1.8%

NFGUnbilled Revenue

$52.96M+7.9%

MOG.BUnbilled Revenue

$842.16M+17.0%

LNTHAccrued Rebates And Discounts Current

$69.88M—

PCGAccrued unbilled revenue (includes $1.3 billion related to VIEs at respective dates)

$1.44B+1.9%

MDGLRebates, Co-Pay Assistance, Returns, and Other — Gross To Net Adjustments Reserve Credits And Payments Made

$94.36M—

Other financials

Income statement

See full

Revenue$392.9M+28.2%

Gross profit$331.3M+28.8%

Operating income-$48.3M-450%

Net income-$66.5M-396%

EPS (diluted)-$0.40-408%

Balance sheet

See full

Cash & equivalents$351.6M-12.1%

Total debt$1.6B+2,034%

Total equity$1.8B+15.9%

Total assets$4.3B+105%

Cash flow

See full

Operating cash flow-$165.7M-268%

CapEx$4.1M-59.5%

Free cash flow-$169.8M-291%

Valuation

See full

Market cap$7.5B+9.7%

Enterprise value$8.73B+41.2%

P/E49.1×+29.7×

P/S4.8×+0.3×

Profitability

See full

Gross margin86.6%+2.2pp

Operating margin12.3%-13.6pp

Net margin9.8%-13.5pp

FCF margin14.2%-17.6pp

Returns & leverage

See full

Return on equity9.4%-16.1pp

Debt / equity0.9×+0.9×

Current ratio2.3×-1.1×

Where this comes from

Reported directly by Alkermes in its filing.

Tagged under the XBRL concept alks:ActualCreditsReceivedRelatedToDuplicateBillings.

The official record: Alkermes’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alkermes's vivitrol — actual credits received related to duplicate billings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alkermes's vivitrol — actual credits received related to duplicate billings?: Alkermes (ALKS) reported vivitrol — actual credits received related to duplicate billings of $5.4M in Q1 2026.
What does vivitrol — actual credits received related to duplicate billings mean?: This metric tracks the financial adjustments or refunds received from customers or distributors due to invoicing errors where the same product shipment was billed multiple times. It serves as an indicator of the operational efficiency and accuracy of the company's accounts receivable and order-to-cash processes. High or recurring values may suggest systemic weaknesses in billing controls or supply chain management.